HYPERTENSION: Matching the right drug to the right patient in essential hypertension
- 1 July 2001
- Vol. 86 (1) , 113-120
- https://doi.org/10.1136/heart.86.1.113
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Activating Mineralocorticoid Receptor Mutation in Hypertension Exacerbated by PregnancyScience, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?Circulation, 1999
- Optimisation of antihypertensive treatment by crossover rotation of four major classesThe Lancet, 1999
- Potentially high prevalence of primary aldosteronism in a primary-care populationThe Lancet, 1999
- Blood pressure screening, management and control in EnglandJournal Of Hypertension, 1998
- Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 geneThe Lancet, 1996
- Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channelCell, 1994
- Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipineJournal Of Hypertension, 1994
- A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertensionNature, 1992